Browsing: Strategies

Radioligand therapies have gone mainstream. Eli Lilly’s $1.4 billion acquisition of Level Biopharma and Novartis’s $23 billion U.S. infrastructure funding…

Sharing a few of the methods I’ve tried to maintain in our lives after our journey. Hello associates! How are…

For self-funded employers, monetary unpredictability can result in a number of issues. As healthcare spend continues to rise, employers are…